Organon (OGN) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Organon (OGN) stood at $8.7, denoting a +1.05% move from the preceding trading day.
Organon (OGN) Increases Despite Market Slip: Here's What You Need to Know
Organon (OGN) reached $8.61 at the closing of the latest trading day, reflecting a +2.14% change compared to its last close.
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing
Organon (OGN) concluded the recent trading session at $7.44, signifying a +2.76% move from its prior day's close.
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Organon (OGN) closed at $6.98, marking a +2.2% move from the previous day.
Is Trending Stock Organon & Co. (OGN) a Buy Now?
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Organon (OGN) Q3 Earnings and Revenues Beat Estimates
Organon (OGN) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.87 per share a year ago.
The Bottom Fishing Club - Organon: Deep Value In Drugs/Medical Products
Organon & Co. shares plunged Monday, October 27th, after CEO Kevin Ali resigned amid an audit committee investigation into wholesaler sales irregularities. Despite the scandal, OGN's valuation at $7 per share is extremely cheap compared to peers, with a diversified product portfolio and global reach. The main risk is OGN's heavy $8.3 billion net debt load, which could hinder share price recovery if revenue growth remains sluggish.
